Bixiye
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2371 - 2380 ee natiijooyinka 3167
Bixiye
P50-20 eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
P49-20 CERiS Review of High Dollar Claims
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP53-20 Commercial Pharmacy Benefit Exclusion for Nexplanon®
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP55-20 Housing Stabilization Services – New MHCP Benefit
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2020
Bixiye
QP49-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema (HAE)
Taariikhda wax ku ool ah ee barnaamijka: Jun 10, 2020